201. Study of biodegradable copoly(l-lactic acid/glycolic acid) formulations with controlled release of Z-100 for application in radiation therapy
- Author
-
Yutaka Hayashi, Itaru Yamaguchi, Masaru Yoshida, Kazuo Matsuda, Hideki Omichi, and Masaharu Asano
- Subjects
Colony-forming unit ,medicine.drug_class ,Lethal dose ,Pharmaceutical Science ,Spleen ,Pharmacology ,Controlled release ,Immunostimulant ,Dosage form ,Lactic acid ,chemistry.chemical_compound ,medicine.anatomical_structure ,chemistry ,Biochemistry ,medicine ,Glycolic acid - Abstract
Z-100, Mycobacterium tuberculosis strain Aoyama B, which suppresses the growth of various experimental tumor cell lines, was incorporated into biodegradable copoly( L -lactic acid/glycolic acid) (70:30 mol%) copolymer with a number-average molecular weight of 2900, in order to evaluate the controlled release function, prolongation of survival duration, and hematopoietic functions such as endogenous colony forming unit of spleen (endogenous CFU-S) and colony forming unit of culture (CFU-C) in mice irradiated with a lethal dose of 8.5 Gy (y-rays from a 6° Co source). In this study, the Z-100 formulation was implanted subcutaneously in the back of mice immediately after irradiation. All of the control mice without the use of the Z-100 formulation died within 19 days, as compared to only 30% mortality throughout the experimental period of 35 days for the experimental mice treated with the Z-100 formulation. Such prolongation of survival time in mice promoted recoveries of stem cells or granulocytic and macrophagic precursor cells.
- Published
- 1995
- Full Text
- View/download PDF